Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Morgan

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
JCI Insight|August 21, 2020
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic targetStefano Pierini, Janos L Tanyi, Fiona Simpkins, et al.
Gynecologic Oncology Reports|February 3, 2022
Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcomaLori Cory, Colleen Brensinger, Robert A Burger, et al.
Gynecologic Oncology|December 17, 2019
Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data BaseDimitrios Nasioudis, Nawar A Latif, Fiona Simpkins, et al.
Gynecologic Oncology|February 25, 2020
Radical hysterectomy is not associated with a survival benefit for patients with stage II endometrial carcinomaDimitrios Nasioudis, Sruthi Sakamuri, Emily M Ko, et al.
Health Information Management : Journal of the Health Information Management Association of Australia|August 15, 2024
Enhancing the quality of medicine handover at hospital discharge: a priority setting workshopH Laetitia Hattingh, Kate Johnston, Matt Percival, et al.
Gynecologic Oncology|May 4, 2020
Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapyDimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
Human Gene Therapy|June 18, 2005
Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinomaFabian Benencia, Maria C Courreges, José R Conejo-García, et al.
Archives of Gynecology and Obstetrics|March 19, 2020
Advanced stage primary mucinous ovarian carcinoma. Where do we stand ?Dimitrios Nasioudis, Benjamin B Albright, Emily M Ko, et al.
Communicable Diseases Intelligence (2018)|September 30, 2021
The ATHENA COVID-19 Study: Cohort profile and first findings for people diagnosed with COVID-19 in Queensland, 1 January to 31 December 2020Jennifer Welsh, Rosemary J Korda, Ellie Paige, et al.
Gynecologic Oncology|May 2, 2020
Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysisDimitrios Nasioudis, Spyridon A Mastroyannis, Nawar A Latif, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
JCI Insight|August 21, 2020
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic targetStefano Pierini, Janos L Tanyi, Fiona Simpkins, et al.
Gynecologic Oncology Reports|February 3, 2022
Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcomaLori Cory, Colleen Brensinger, Robert A Burger, et al.
Gynecologic Oncology|December 17, 2019
Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data BaseDimitrios Nasioudis, Nawar A Latif, Fiona Simpkins, et al.
Gynecologic Oncology|February 25, 2020
Radical hysterectomy is not associated with a survival benefit for patients with stage II endometrial carcinomaDimitrios Nasioudis, Sruthi Sakamuri, Emily M Ko, et al.
Health Information Management : Journal of the Health Information Management Association of Australia|August 15, 2024
Enhancing the quality of medicine handover at hospital discharge: a priority setting workshopH Laetitia Hattingh, Kate Johnston, Matt Percival, et al.
Gynecologic Oncology|May 4, 2020
Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapyDimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
Human Gene Therapy|June 18, 2005
Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinomaFabian Benencia, Maria C Courreges, José R Conejo-García, et al.
Archives of Gynecology and Obstetrics|March 19, 2020
Advanced stage primary mucinous ovarian carcinoma. Where do we stand ?Dimitrios Nasioudis, Benjamin B Albright, Emily M Ko, et al.
Communicable Diseases Intelligence (2018)|September 30, 2021
The ATHENA COVID-19 Study: Cohort profile and first findings for people diagnosed with COVID-19 in Queensland, 1 January to 31 December 2020Jennifer Welsh, Rosemary J Korda, Ellie Paige, et al.
Gynecologic Oncology|May 2, 2020
Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysisDimitrios Nasioudis, Spyridon A Mastroyannis, Nawar A Latif, et al.
Pageof 9